Frequently Asked Questions
The market is segmented based on Global Point-of-Care-Ultrasound Device Market, By Type (Diagnostic and Therapeutic), Portability (Trolley/ Cart-Based and Compact/ Handheld), Application (Emergency Medicine, Cardiology, Obstetrics and Gynecology, Oncology Surgery, Urology, Vascular surgery, Musculoskeletal and Others), End User (Hospitals, Diagnostic Centers, Research Laboratories, Clinics, Ambulatory Surgical Centers and Others) – Industry Trends and Forecast to 2030.
.
The Global Point Of Care Ultrasound Device Market size was valued at USD 2324.12 USD Million in 2022.
The Global Point Of Care Ultrasound Device Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include GSK, F. Hoffmann, La Roche, Novartis, Astrazeneca, Pfizer, Bristol Myers Squibb, Sanofi, Amgen, Daiichi Sankyo, AB Sciences, Eisai, Genentech, Merck & Co..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
